Clinical Trial Update: Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes

View source ↗

Summary

A completed AstraZeneca-sponsored clinical trial update examining patient characteristics, treatment patterns, and outcomes in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Non-small Cell Lung Cancer | Status: COMPLETED